Impact Factor: 1.5

Journal Open Access

Heterocyclic Communications

Editor-in-Chief: Maged Henary
Maged Henary

Search for this author in:

De Gruyter De Gruyter Brill | Google Scholar

Language: English

First published: January 1, 1994

Publication Frequency: 1 issue per year

View latest issue

Published by

Become an author with De Gruyter Brill

Submit Manuscript Author Information Explore this Subject

About this journal

Heterocyclic Communications is an open-access, peer-reviewed journal committed to publishing preliminary communications, research articles, and reviews on significant developments in all phases of heterocyclic chemistry, including general synthesis, natural products, computational analysis, considerable biological activity and inorganic ring systems.

It is poised to captivate a diverse readership across the fields of chemistry, biology, and biotechnology, including scholars who would like to gain profound insights into the latest scientific breakthroughs, as well as non-scholarly readers, who seek to expand their knowledge and deepen their understanding with reference to the newest discoveries in the field of science.

Heterocyclic Communications assures the top quality of published data through critical peer-review and editorial involvement throughout the entire publication process. Clear presentation of experimental and computational data is strongly emphasized. Thanks to the Open Access model, it also offers unrestricted access to published articles for all users.

The published content includes research articles, review articles, and preliminary communications.

Aims and Scope

The journal aims to facilitate the communication and collaboration of scientists across different countries.

Heterocyclic chemistry is a rapidly growing field. By some estimates original research papers in heterocyclic chemistry have increased to more than 60% of the current organic chemistry literature published. This explosive growth is even greater when considering heterocyclic research published in materials science, physical, biophysical, analytical, bioorganic, pharmaceutical, medicinal and natural products journals. There is a need, therefore, for a journal dedicated explicitly to heterocyclic chemistry and the properties of heterocyclic compounds.

The scope of Heterocyclic Communications is covers scholarly research in:

Development of novel synthetic methods

Significant improvement of known synthetic methods

Chemistry of natural products

Superior biological activity of novel heterocyclic compounds, rational design and synthesis of new drug candidates targeting specific biological receptors

Application of heterocyclic compounds as probes for biomolecules in biophysical and bioanalytical chemistry

Development of new substrates and catalysts in materials chemistry

Your Benefits

Why submit

As an Author of Heterocylic Communications, You benefit from:

fair and constructive peer review

quick online publication of accepted papers (continuous publication model)

language correction services upon acceptance for authors from non-English speaking regions

no limitations on colour figures and word count in published articles

all articles are freely available to the academic community worldwide without any restrictions

promotion of published papers to readers and citers

distribution to open access directories (such as DOAJ) and thousands of libraries worldwide

liberal policies on copyrights (authors retain copyright) and on self-archiving (no embargo periods)

secure archiving by De Gruyter and the independent archiving service Portico

Why read

You can access all significant developments in heterocyclic chemistry

We cover synthetic routes to heterocyclic compounds with high biological activity

Researchers use journal as a platform to reveal data that is likely to advance the direction and the thinking of the field

It is an international forum for the dissemination of research data in field of heterocylic chemistry

The publication is designed to facilitate the exchange of ideas between researchers from different countries

Topical/Special Issues:

You can also submit your Special Issue proposal by contacting Managing Editor at Izabela.Zarczynska@degruyter.com

Article Processing Charges

In order to sustain the publishing process, each article accepted for publication in Heterocyclic Communications is subject to an Article Processing Charge of €1600. This fee is used to cover the costs of the peer-review process, professional typesetting and copyediting, as well as online hosting, long-term preservation, and extensive promotion to potential readers. There is no submission fee. Information regarding payment of the charge will be provided following acceptance for publication. For more information please go to Article Processing Charges.

Publication Ethics and Editorial Policies

Detailed information on Editorial Policy, Publication Ethics, Instructions for Authors etc. can be found in the Supplementary Materials section.

For more information on De Gruyter Publishing Ethics, please see the De Gruyter Guidelines online here.

Conferences/Events

Conference/Event Managers interested in starting a collaboration are encouraged to submit their proposal by contacting Managing Editor at Izabela.Zarczynska@degruyter.com

Issue 1

Journal Impact Factor	1.5	2024, Journal Citation Reports (Clarivate, 2025)
5-year Journal Impact Factor	2.2	2024, Journal Citation Reports (Clarivate, 2025)
Journal Citation Indicator	0.42	2024, Journal Citation Reports (Clarivate, 2025)
CiteScore	3.4	2024, Scopus (Elsevier B.V., 2025)
SCImago Journal Rank	0.292	2024, SJR (Scimago Lab, 2025; Data Source: Scopus)
Source Normalized Impact per Paper	0.479	2024, CWTS Journal Indicators (CWTS B.V., 2025; Data Source: Scopus)

More information about journal rankings

MANUSCRIPTS

Heterocyclic Communications encourages the submission of both substantial full-length bodies of work and shorter manuscripts that report novel findings. There are no specific length restrictions for the overall manuscript or individual sections; however, we urge the authors to present and discuss their findings in a concise and accessible manner.

All submissions must be made via online submission system Editorial Manager. In case of problems, please contact the Managing Editor of this journal (izabela.zarczynska@degruyter.com).

SUBMISSION OF MANUSCRIPTS

Manuscripts have to be written in MS Word. For your initial submission, we recommend you upload your entire manuscript, including tables and figures, as a single PDF file. If you are invited to submit a revised manuscript, please provide us with individual files: an editable text and publication-quality figures.

For detailed information, please see Instruction for Authors.

EDITORIAL POLICY

Unpublished material: Submission of a manuscript implies that the work described is not copyrighted, published or submitted elsewhere, except in abstract form. The corresponding author should ensure that all authors approve the manuscript before its submission.

Ethical conduct of research: The authors must describe and confirm safeguards to meet ethical standards when applicable. See Editorial Policy for details.

Conflict of interest: When authors submit a manuscript, they are responsible for recognizing and disclosing financial and/or other conflicts of interest that might bias their work and/or could inappropriately influence his/her judgment. If no specified acknowledgement is given, the Editors assume that no conflict of interest exists. Authors are encouraged to fill in the ICMJE Conflicts of Interest Form (available here) and send it in the electronic format to the Managing Editor.

Copyright: All authors retain copyright, unless – due to their local circumstances – their work is not copyrighted. The copyrights are governed by the Creative-Commons Attribution Only license (CC-BY) which is compliant with Plan-S. The corresponding author grants the journal the license to use of the article, by signing the License To Publish. Scanned copy of license should be sent to the journal, as soon as possible.

Authorship: Authorship should be limited to those who have made a significant contribution to the conception, design, execution, or interpretation of the reported study. All those who have made significant contributions should be listed as co-authors. Where there are others who have participated in certain substantive aspects of the research project, they should be named in an Acknowledgement section. The corresponding author should ensure that all appropriate co-authors (according to the above definition) and no inappropriate co-authors are included in the author list of the manuscript, and that all co-authors have seen and approved the final version of the paper and have agreed to its submission for publication.

Peer Review process: Our standard policy requires each paper reporting primary research or secondary analysis of primary research, together with relevant supplementary materials, to be reviewed by at least two Referees and the peer-review process is single-blind. The Editors reserve the right to decline the submitted manuscript without review, if the studies reported are not sufficiently novel or important to merit publication in the journal. Manuscripts deemed unsuitable (insufficient originality or of limited interest to the target audience) are returned to the author(s) without review. The Editor seeks advice from experts in the appropriate field. Research articles and communications are refereed by a minimum of two reviewers, review papers by at least three. Authors are requested to suggest persons competent to review their manuscript. However, please note that this will be treated only as a suggestion, and the final selection of reviewers is exclusively the Editor's decision. The final decision of acceptance in made by Managing Editor or, in case of conflict, by the Editor-in-Chief.

Scientific Misconduct: This journal publishes only original manuscripts that are not also published or going to be published elsewhere. Multiple submissions/publications, or redundant publications (re-packaging in different words of data already published by the same authors) will be rejected. If they are detected only after publication, the journal reserves the right to publish a Retraction Note. In each particular case Editors will follow COPE’s Core Practices and implement the advices.

Editor-in Chief
Maged Henary, Department of Chemistry, Georgia State University, Atlanta, USA

Managing Editor
Izabela Żarczynska
Izabela.Zarczynska@degruyter.com

Honorary Editor
Lucjan Strekowski, Georgia State University, Atlanta, USA

Associate Editors
Alfons Baumstark, Georgia State University, Atlanta, USA
Naresh Gunaganti, Northeastern University, Boston, USA
Yuliang Li, Chang’an University, China
Ajay Mallia, Georgia Gwinnett College, Lawrenceville, USA
Sarbjit Singh, University of Nebraska Medical Center, Omaha, USA
Subhash D. Tanpure, Adesis Inc. - A Universal Display Company, Delaware, USA
Kun Zhao, Chubu University, Kasugai, Japan
Wei Zhu, Northwestern University, Evanston, USA

Editorial Board
S. Abu-Orabi, Association of Arab Universities, Amman, Jordan
S. Achilefu, Washington University, St. Louis, USA
E.B. Arevalo-Garcia, Educational Research Institute, Warsaw, Poland
M. Brimble, University of Auckland, Auckland, New Zealand
R.A. Bunce, Oklahoma State University, Stillwater, USA
D. Das, Johns Hopkins School of Medicine, Baltimore, USA
M. Elliott, University of Cardiff, Cardiff, UK
D.C. Gautam, University of Rajasthan, Jaipur, India
M.W. Germann, Georgia State University, Atlanta, USA
S. Gozem, Georgia State University, Atlanta, USA
D. Hamelberg, Georgia State University, Atlanta, USA
H. Kiyota, Okayama University, Okayama, Japan
K. Kiec-Kononowicz, Jagiellonian University, Kraków, Poland
M. Kumar, University of Rajasthan, Jaipur, India
H. Nishino, Kumamoto University, Kumamoto, Japan
T. Okano, Jikei University, Tokyo, Japan
S.S. Panda, Augusta University, Augusta, USA
S.E. Patterson, UMN Center for Drug Design, Minneapolis, USA
J. Reddy, Dr. Jagath Reddy's Heterocyclics, Hyderabad, India
S. Routier, University of Orléans, Orléans, France
A. Rykowski, University of Podlasie, Siedlce, Poland
S.W. Schneller, University of Auburn, Auburn, USA
B.C.G. Söderberg, University of West Virginia, Morgantown, USA
V. Traven, Russian University of Chemical Technology, Moscow, Russia
B. Wang, Georgia State University, Atlanta, USA
K. Weisz, Ernst Moritz Arndt University, Greifswald, Germany
P.-F. Xu, Lanzhou University, Lanzhou, China
P. Zajdel, Jagiellonian University Medical College, Kraków, Poland
N. Zaware, Mount Sinai School of Medicine, New York, USA
A. Zawisza, University of Łódź, Łódź, Poland